| Industry | Status | Date | Ticker(s) | issuer(s) | MO | SP | FI | Size (M) | Ranking | TNR | Call | MTY | Coupon | Leads | product | Region | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
HLTH | PRCD | Sep 8, 2026 | GSK | GlaxoSmithKline Capital Inc | A2 | A | - | $1,250 | Sr. Unsecured | 3.00 | - | Sep-29 | 4.850% | BAM, BNP, ... | IGC | USOA | |||
HLTH | PRCD | Sep 8, 2026 | GSK | GlaxoSmithKline Capital Inc | A2 | A | - | $500 | Sr. Unsecured | 3.00 | - | Sep-29 | SOFR+56 | BAM, BNP, ... | IGC | USOA | |||
HLTH | PRCD | Sep 8, 2026 | GSK | GlaxoSmithKline Capital Inc | A2 | A | - | $1,250 | Sr. Unsecured | 5.00 | - | Sep-31 | 5.10% | BAM, BNP, ... | IGC | USOA | |||
HLTH | PRCD | Sep 8, 2026 | GSK | GlaxoSmithKline Capital Inc | A2 | A | - | $1,500 | Sr. Unsecured | 7.00 | - | Sep-33 | 5.25% | BAM, BNP, ... | IGC | USOA | |||
HLTH | PRCD | Sep 8, 2026 | GSK | GlaxoSmithKline Capital Inc | A2 | A | - | $1,500 | Sr. Unsecured | 10.00 | - | Sep-36 | 5.50% | BAM, BNP, ... | IGC | USOA | |||
HLTH | PRCD | Sep 8, 2026 | GSK | GlaxoSmithKline Capital Inc | A2 | A | - | $500 | Sr. Unsecured | 30.00 | - | Sep-56 | 6.05% | BAM, BNP, ... | IGC | USOA | |||
HLTH | PRCD | Aug 4, 2026 | ABBV | Abbvie Inc | A2 | A- | - | $500 | Sr. Unsecured | 2.00 | - | Aug-28 | SOFR+42 | BAM, JPM, ... | IGC | USOA | |||
HLTH | PRCD | Aug 4, 2026 | ABBV | Abbvie Inc | A2 | A- | - | $1,000 | Sr. Unsecured | 2.00 | - | Aug-28 | 4.50% | BAM, JPM, ... | IGC | USOA | |||
HLTH | PRCD | Aug 4, 2026 | ABBV | Abbvie Inc | A2 | A- | - | $1,250 | Sr. Unsecured | 3.50 | - | Mar-30 | 4.65% | BAM, JPM, ... | IGC | USOA | |||
HLTH | PRCD | Aug 4, 2026 | ABBV | Abbvie Inc | A2 | A- | - | $1,500 | Sr. Unsecured | 5.00 | - | Sep-31 | 4.875% | BAM, JPM, ... | IGC | USOA |